Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS
- PMID: 35181813
- PMCID: PMC9115043
- DOI: 10.1245/s10434-022-11429-z
Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS
Conflict of interest statement
References
-
- Elias D, Gilly F, Quenet F, Bereder JM, Sideris L, Mansvelt B, et al.; Association Francaise de Chirurgie. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36(5):456–62. doi: 10.1016/j.ejso.2010.01.006. - DOI - PubMed
-
- Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA. Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. Ann Surg Oncol. 2015;22(4):1274–9. 10.1245/s10434-014-4147-y. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical